Company presentation - Mondobiotech
Company presentation - Mondobiotech
Company presentation - Mondobiotech
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The orphan market<br />
• Worldwide, the orphan drug market reached<br />
$84.9 billion in 2009. The market is expected<br />
to grow at a compound annual growth<br />
rate (CAGR) of nearly 6% to reach $112.1 billion<br />
by 2014. The US accounted for 51% of the<br />
market in 2009 and is expected to grow at<br />
a CAGR of 8.9% to reach $65.9 billion by 2014.<br />
• The total worldwide market for orphan<br />
drugs, including sales for non-orphan<br />
applications, exceeded $28 billion in 2003. The<br />
market reached $58.7 billion in 2006, growing<br />
by 8% from $54.5 billion in 2005<br />
in orphan applications only.<br />
• Biological drugs accounted for a major share<br />
(64.3%) of the orphan drug market with sales<br />
of $54.6 billion in 2009, up from $51.4 billion<br />
(Source: www.bccresearch.com/report/PHM038C.html, published:<br />
May 2010, analyst: Syamala Ariyanchira, and reports of 2004 and 2007)<br />
in 2008. The size of the biological orphan drug<br />
market is projected to grow<br />
at a 6.9% CAGR to reach $76.2 billion by 2014.<br />
• In 2009 there were a total of more then<br />
350 orphan drugs approved in USA<br />
and 62 in Europe.<br />
• 57 drugs exceeded yearly sales of $200<br />
million and 27 of those exceeded sales<br />
of $1 billion.<br />
10/33
Change language